Jablonka Sibylle, Beck Marcus, Lechner Barbara Dorothea, Mayer Christine, Sendtner Michael
Institute for Clinical Neurobiology, University of Wuerzburg, Wuerzburg D-97078, Germany.
J Cell Biol. 2007 Oct 8;179(1):139-49. doi: 10.1083/jcb.200703187.
Proximal spinal muscular atrophy (SMA) is a motoneuron disease for which there is currently no effective treatment. In animal models of SMA, spinal motoneurons exhibit reduced axon elongation and growth cone size. These defects correlate with reduced beta-actin messenger RNA and protein levels in distal axons. We show that survival motoneuron gene (Smn)-deficient motoneurons exhibit severe defects in clustering Cav2.2 channels in axonal growth cones. These defects also correlate with a reduced frequency of local Ca2+ transients. In contrast, global spontaneous excitability measured in cell bodies and proximal axons is not reduced. Stimulation of Smn production from the transgenic SMN2 gene by cyclic adenosine monophosphate restores Cav2.2 accumulation and excitability. This may lead to the development of new therapies for SMA that are not focused on enhancing motoneuron survival but instead investigate restoration of growth cone excitability and function.
近端脊髓性肌萎缩症(SMA)是一种目前尚无有效治疗方法的运动神经元疾病。在SMA动物模型中,脊髓运动神经元的轴突伸长和生长锥大小减小。这些缺陷与远端轴突中β-肌动蛋白信使核糖核酸和蛋白质水平降低相关。我们发现,生存运动神经元基因(Smn)缺陷的运动神经元在轴突生长锥中聚集Cav2.2通道时表现出严重缺陷。这些缺陷还与局部Ca2+瞬变频率降低相关。相比之下,在细胞体和近端轴突中测量的整体自发兴奋性并未降低。通过环磷酸腺苷刺激转基因SMN2基因产生Smn可恢复Cav2.2的积累和兴奋性。这可能会导致开发出针对SMA的新疗法,这些疗法不侧重于提高运动神经元的存活率,而是研究恢复生长锥的兴奋性和功能。